BioLamina raised €20M in a funding round in Apr 2026. The company is based in Stockholm, Sweden. Investors in the round: European Investment Bank (EIB). Data as of 21 Sept 2026.
Reported in EUR — no conversion. €20M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
